CLBy Calypso Research6 min read

Colgate-Palmolive Company (CL) Q4 2025 Earnings Analysis

Smile Wide with $5.2B as Colgate Brushes Off Challenges

Key Takeaways

Colgate-Palmolive Company (CL) reported Q4 2025 earnings with revenue of $5.2B, representing a +5.8% year-over-year change. The stock moved +5.9% on earnings day.

The bull case: Premiumization and strategic pricing in developed and emerging markets drive long-term margin expansion and organic growth.

The bear case: U.S. category challenges and competitive pressures may limit top-line growth and compress margins in the near term.

Financial Highlights

  • Revenue: $5.2B (+5.8% YoY)
  • Gross Profit: $3.1B (60.2% margin, -0.2% YoY)
  • Operating Income: $1.1B (20.6% margin, -1.5% YoY)
  • Net Income: $-37M
  • TTM Revenue: $20.4B

Stock Performance

  • Earnings Day Move: +5.9%
  • Year-to-Date: +25.0%
  • 1-Year Return: +7.8%
  • vs. S&P 500 (since earnings): +19.2%
  • vs. Nasdaq (since earnings): +22.0%

View live CL data, AI chat, and interactive debates on Calypso →

What Management Said

Here are the key debates and direct quotes from Colgate-Palmolive Company's Q4 2025 earnings call:

U.S. Category Growth and Innovation to Drive Premiumization

Sentiment: Positive

"Clearly, we've got some pricing opportunities as I laid out earlier on whether it's revenue growth management or going after the premiumization segment...but our belief is that the right value is to drive more premium innovation." — Noel Wallace
"It's critically important to drive growth in the U.S. across all price points, and we clearly will match any competitive activity that happens, but we're very focused on driving the category much more through innovation." — Noel Wallace

Currency Tailwinds and Pricing Strategies in Emerging Markets

Sentiment: Mixed

"...we don't plan nor do we build our plans based on foreign exchange being a benefit for us...if we need to take pricing because our products require it and the cost of the formulations require it, we will take what the market can bear." — Noel Wallace
"Even if you go back and look at those 2 years where FX was favorable, we actually executed pricing in those 2 years as well...we have very experienced teams on the ground around the world. They know how to navigate this market." — Stanley Sutula

Hill’s Pet Nutrition Performance Amidst Challenging Category Dynamics

Sentiment: Positive

"Therapeutic continues to be a big growth driver for us. The Prescription Diet business growing very, very nicely with improved obviously, market shares, and that clearly helps the mix in the operating margins and gross profits." — Noel Wallace
"Private label was a 360 basis points negative impact to volume. And despite that...we grew volume 2%, which is terrific. And that growth was pretty broad-based with the exception of the softness we continue to see in the category behind dry." — Noel Wallace

Advertising Spend Strategy and Returns in a Challenging Consumer Backdrop

Sentiment: Mixed

"While the advertising on the percent of sales was down a little bit in the fourth quarter, it was still up 5% on a dollar basis year-on-year, which is good in terms of the number of impressions and the impact we're getting in the market." — Noel Wallace
"We have areas of the world and brands that we believe will continue to benefit immensely from improved advertising and increased levels of advertising in the market in order to drive not only our market share and penetration but to drive the categories as well." — Noel Wallace

M&A Strategy and Portfolio Optimization

Sentiment: Positive

"We always look at our options to improve our portfolio of businesses...if you look over the last few years, we saw those opportunities predominantly in Hill’s. We’ve made those investments and Red Collar and in Prime 100." — Stanley Sutula
"...rest assured that if we found the right opportunity to utilize our balance sheet, we would...but we are, as you well know, cautious and we want to manage through this uncertain environment in the right way." — Noel Wallace

Bull Case

Premiumization and strategic pricing in developed and emerging markets drive long-term margin expansion and organic growth.

Bear Case

U.S. category challenges and competitive pressures may limit top-line growth and compress margins in the near term.

Looking Ahead

Investors will be closely watching Colgate-Palmolive Company's next quarterly report for continued execution, particularly around u.S. Category Growth and Innovation to Drive Premiumization. With operating margins at 20.6%, margin trends will remain a focal point. The market's positive reaction on earnings day suggests confidence in management's direction, and the next earnings report will be a key catalyst for the stock.

Frequently Asked Questions

What was Colgate-Palmolive Company's revenue in Q4 2025?

Colgate-Palmolive Company reported Q4 2025 revenue of $5.2B, representing a +5.8% year-over-year change.

Did Colgate-Palmolive Company beat earnings expectations in Q4 2025?

The stock rose +5.9% on earnings day, suggesting the results met or exceeded market expectations. The current bull case centers on: Premiumization and strategic pricing in developed and emerging markets drive long-term margin expansion and organic growth.

What is the bull case for CL stock?

The bull case for CL centers on: Premiumization and strategic pricing in developed and emerging markets drive long-term margin expansion and organic growth.

What is the bear case for CL stock?

The bear case for CL centers on: U.S. category challenges and competitive pressures may limit top-line growth and compress margins in the near term.

How has CL stock performed since its Q4 2025 earnings?

CL moved +5.9% on the day of its Q4 2025 earnings report, outperforming the S&P 500 by +19.2% since earnings. Year-to-date, the stock has returned +25.0%.

Browse all 400+ earnings reports →

Learn More

Analyze CL in Real Time

This is a static snapshot. For live financial data, AI-powered chat, and interactive earnings debates for Colgate-Palmolive Company and 400+ other stocks, explore the full platform.

Open CL on Calypso →

Calypso is an AI-powered equity research platform used by investment teams to cut earnings research time by over 80%.